BIOMAT Database Logo BIOMAT Database Logo

Adrenocortical tumor in a patient with untreated congenital adrenocortical hyperplasia owing to 21-hydroxylase deficiency: characterization of steroidogenic lesions. 1988

K Takayama, and M Ohashi, and M Haji, and T Matsumoto, and Y Mihara, and J Kumazawa, and K Kato
Department of Urology, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

We report a case of congenital adrenal hyperplasia complicated by a right adrenal adenoma. The congenital adrenal hyperplasia was confirmed by extremely high levels of basal serum 17 alpha-hydroxy-progesterone and urinary pregnantriol as well as an exaggerated response of 17 alpha-hydroxyprogesterone to adrenocorticotropic hormone. On roentogenographic examinations and an echogram a huge calcified tumor was seen in the right adrenal gland. Histological findings indicated an adrenocortical adenoma. Culture of the tumor cells showed an accentuated response in the ratio of 17 alpha-hydroxy-progesterone to desoxycortisol with adrenocorticotropic hormone as a stimulator, suggesting that such adenoma cells also lack 21-hydroxylase activity. Our study clearly demonstrates that tumor cells have the same steroidogenic lesions as hyperplasia.

UI MeSH Term Description Entries
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006899 Mixed Function Oxygenases Widely distributed enzymes that carry out oxidation-reduction reactions in which one atom of the oxygen molecule is incorporated into the organic substrate; the other oxygen atom is reduced and combined with hydrogen ions to form water. They are also known as monooxygenases or hydroxylases. These reactions require two substrates as reductants for each of the two oxygen atoms. There are different classes of monooxygenases depending on the type of hydrogen-providing cosubstrate (COENZYMES) required in the mixed-function oxidation. Hydroxylase,Hydroxylases,Mixed Function Oxidase,Mixed Function Oxygenase,Monooxygenase,Monooxygenases,Mixed Function Oxidases,Function Oxidase, Mixed,Function Oxygenase, Mixed,Oxidase, Mixed Function,Oxidases, Mixed Function,Oxygenase, Mixed Function,Oxygenases, Mixed Function
D000236 Adenoma A benign epithelial tumor with a glandular organization. Adenoma, Basal Cell,Adenoma, Follicular,Adenoma, Microcystic,Adenoma, Monomorphic,Adenoma, Papillary,Adenoma, Trabecular,Adenomas,Adenomas, Basal Cell,Adenomas, Follicular,Adenomas, Microcystic,Adenomas, Monomorphic,Adenomas, Papillary,Adenomas, Trabecular,Basal Cell Adenoma,Basal Cell Adenomas,Follicular Adenoma,Follicular Adenomas,Microcystic Adenoma,Microcystic Adenomas,Monomorphic Adenoma,Monomorphic Adenomas,Papillary Adenoma,Papillary Adenomas,Trabecular Adenoma,Trabecular Adenomas
D000306 Adrenal Cortex Neoplasms Tumors or cancers of the ADRENAL CORTEX. Adrenocortical Cancer,Cancer of Adrenal Cortex,Adrenal Cortex Cancer,Cancer of the Adrenal Cortex,Neoplasms, Adrenal Cortex,Adrenal Cortex Cancers,Adrenal Cortex Neoplasm,Adrenocortical Cancers,Cancer, Adrenal Cortex,Cancer, Adrenocortical,Cancers, Adrenal Cortex,Cancers, Adrenocortical,Neoplasm, Adrenal Cortex
D000312 Adrenal Hyperplasia, Congenital A group of inherited disorders of the ADRENAL GLANDS, caused by enzyme defects in the synthesis of cortisol (HYDROCORTISONE) and/or ALDOSTERONE leading to accumulation of precursors for ANDROGENS. Depending on the hormone imbalance, congenital adrenal hyperplasia can be classified as salt-wasting, hypertensive, virilizing, or feminizing. Defects in STEROID 21-HYDROXYLASE; STEROID 11-BETA-HYDROXYLASE; STEROID 17-ALPHA-HYDROXYLASE; 3-beta-hydroxysteroid dehydrogenase (3-HYDROXYSTEROID DEHYDROGENASES); TESTOSTERONE 5-ALPHA-REDUCTASE; or steroidogenic acute regulatory protein; among others, underlie these disorders. Congenital Adrenal Hyperplasia,Hyperplasia, Congenital Adrenal,Adrenal Hyperplasias, Congenital,Congenital Adrenal Hyperplasias,Hyperplasias, Congenital Adrenal
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013256 Steroids A group of polycyclic compounds closely related biochemically to TERPENES. They include cholesterol, numerous hormones, precursors of certain vitamins, bile acids, alcohols (STEROLS), and certain natural drugs and poisons. Steroids have a common nucleus, a fused, reduced 17-carbon atom ring system, cyclopentanoperhydrophenanthrene. Most steroids also have two methyl groups and an aliphatic side-chain attached to the nucleus. (From Hawley's Condensed Chemical Dictionary, 11th ed) Steroid,Catatoxic Steroids,Steroids, Catatoxic
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured

Related Publications

K Takayama, and M Ohashi, and M Haji, and T Matsumoto, and Y Mihara, and J Kumazawa, and K Kato
Adrenocortical tumor in a patient with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
August 1981, Pediatrics,
K Takayama, and M Ohashi, and M Haji, and T Matsumoto, and Y Mihara, and J Kumazawa, and K Kato
Congenital adrenal hyperplasia owing to 21-hydroxylase deficiency.
March 2001, Endocrinology and metabolism clinics of North America,
K Takayama, and M Ohashi, and M Haji, and T Matsumoto, and Y Mihara, and J Kumazawa, and K Kato
[Congenital adrenal hyperplasia owing to 21-hydroxylase deficiency presenting with erythrocytosis].
November 2008, Medicina clinica,
K Takayama, and M Ohashi, and M Haji, and T Matsumoto, and Y Mihara, and J Kumazawa, and K Kato
Untreated congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
July 2009, European journal of pediatrics,
K Takayama, and M Ohashi, and M Haji, and T Matsumoto, and Y Mihara, and J Kumazawa, and K Kato
Masculinizing operation for a female patient with congenital adrenocortical hyperplasia due to 21-hydroxylase deficiency.
November 1985, Hinyokika kiyo. Acta urologica Japonica,
K Takayama, and M Ohashi, and M Haji, and T Matsumoto, and Y Mihara, and J Kumazawa, and K Kato
Prenatal diagnosis and treatment of congenital adrenal hyperplasia owing to 21-hydroxylase deficiency.
May 2007, Nature clinical practice. Endocrinology & metabolism,
K Takayama, and M Ohashi, and M Haji, and T Matsumoto, and Y Mihara, and J Kumazawa, and K Kato
Congenital adrenal hyperplasia owing to 11β-hydroxylase deficiency.
January 2011, Advances in experimental medicine and biology,
K Takayama, and M Ohashi, and M Haji, and T Matsumoto, and Y Mihara, and J Kumazawa, and K Kato
Congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Growth, development, and therapeutic considerations.
March 2001, Endocrinology and metabolism clinics of North America,
K Takayama, and M Ohashi, and M Haji, and T Matsumoto, and Y Mihara, and J Kumazawa, and K Kato
Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency.
February 2013, Proceedings of the National Academy of Sciences of the United States of America,
K Takayama, and M Ohashi, and M Haji, and T Matsumoto, and Y Mihara, and J Kumazawa, and K Kato
Prenatal treatment and diagnosis of congenital adrenal hyperplasia owing to steroid 21-hydroxylase deficiency.
July 1995, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!